Long Island Wealth Management’s AbbVie ABBV Stock Holding History

Long Island Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Buy	1,184 +23	+2%	+$4.95K	0.12%	76
2026 Q1	$252K	Buy	1,161 +23	+2%	+$5.1K	0.12%	79
2025 Q4	$260K	Buy	1,138 +93	+9%	+$21.2K	0.12%	75
2025 Q3	$242K	Buy	+1,045	New	+$213K	0.12%	77
2025 Q2	–	Sell	-1,008	Closed	-$211K	–	82
2025 Q1	$211K	Buy	+1,008	New	+$196K	0.13%	75
2024 Q1	–	Sell	-953	Closed	-$148K	–	76
2023 Q4	$148K	Buy	+953	New	+$139K	0.11%	83

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Long Island Wealth Management's ABBV Position: Q2 2026 in Review

Long Island Wealth Management increased its AbbVie (ABBV) stake by 2% in Q2 2026, buying an estimated $4.95K and bringing the position to 1,184 shares worth $298K. The position accounts for 0.12% of the portfolio, ranked #76.

Long Island Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 6 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Long Island Wealth Management held 1,184 shares of AbbVie worth $298K as of Q2 2026.
Long Island Wealth Management bought 23 AbbVie shares in Q2 2026, an estimated $4.95K.
AbbVie made up 0.12% of Long Island Wealth Management's portfolio in Q2 2026, its #76 holding.
Long Island Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 6 quarters since.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Long Island Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.